Cerezyme

Cerezyme

imiglucerase

Manufacturer:

Sanofi

Distributor:

DCH Auriga - Healthcare
Concise Prescribing Info
Contents
Imiglucerase
Indications/Uses
Long-term enzyme replacement therapy for patients w/ a confirmed diagnosis of type 1 or 3 Gaucher disease that results in anemia, thrombocytopenia, bone disease, hepatomegaly or splenomegaly.
Dosage/Direction for Use
By IV infusion over 1-2 hr. Initial Dose: 60 u/kg once every 2 wk. Individualised dosage adjustments.
Contraindications
Hypersensitivity.
Special Precautions
Monitor periodically for IgG antibody formation during the 1st yr. Anaphylactoid reactions (immediate discontinuation). Controlled Na diet. Pregnancy & lactation.
Adverse Reactions
Dyspnoea, coughing, hypersensitivity reactions, urticaria/angioedema, pruritus, rash.
ATC Classification
A16AB02 - imiglucerase ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.
Presentation/Packing
Form
Cerezyme inj 400 U
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in